
The new guidelines are specifically designed to increase access to testing and eligibility for treatment for patients in sub-Saharan Africa, which accounts for 70% of all new HBV infections. Read more.

The new guidelines are specifically designed to increase access to testing and eligibility for treatment for patients in sub-Saharan Africa, which accounts for 70% of all new HBV infections. Read more.